| Darlene R Nelson, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Darlene R Nelson |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 19 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891702064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 48605 (Minnesota) | Primary |
| 207R00000X | Internal Medicine | 48605 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Seeking to improve the reliability of medical testing, an international team of top experts is releasing new guidelines for doctors and scientists on how to best report their assessments of new and existing diagnostic tests.
Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Americans are eating safer. The number of people who reported eating one or more foods associated with an increased risk of foodborne disease declined by a third from 1998 to 2002, according to survey results released at the International Conference on Emerging Infectious Diseases.
Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.
› Verified 7 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Seeking to improve the reliability of medical testing, an international team of top experts is releasing new guidelines for doctors and scientists on how to best report their assessments of new and existing diagnostic tests.
Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Americans are eating safer. The number of people who reported eating one or more foods associated with an increased risk of foodborne disease declined by a third from 1998 to 2002, according to survey results released at the International Conference on Emerging Infectious Diseases.
Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darlene R Nelson, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Darlene R Nelson, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Seeking to improve the reliability of medical testing, an international team of top experts is releasing new guidelines for doctors and scientists on how to best report their assessments of new and existing diagnostic tests.
Researchers from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have conducted a study that failed to show a difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Americans are eating safer. The number of people who reported eating one or more foods associated with an increased risk of foodborne disease declined by a third from 1998 to 2002, according to survey results released at the International Conference on Emerging Infectious Diseases.
Tulane University has added a second avenue for COVID-19 testing, this one taking place at a Tulane School of Medicine repurposed research lab where results can be processed within a day.
› Verified 7 days ago
Emily Leasure, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Jorge A Velosa, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michael Ruediger Mueller, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mr. Karun Singh Badwal, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Michal Reid, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Katherine Desprez Wick, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Allison Bock, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |